Professional Summary »
Specializing In »
Practice Locations »
Referring Physicians »
Specializing In
- Blistering Diseases
- Epidermolysis Bullosa
Biography
Phuong Khuu, M.D., is a Clinical Assistant Professor in Pediatric Dermatology at Lucile Packard Children’s Hospital. Her clinical interests include children with complex dermatologic diseases and epidermolysis bullosa. Her research interest is in clinical management of epidermolysis bullosa.
View Full Biography »
Professional Summary
Education & Certifications
- Residency: University of California San Francisco (2005) CA
- Internship: University of California San Francisco (2003) CA
- Medical Education: University of California at San Francisco School of Medicine (2002) CA
- Residency: Stanford University Hospital and Clinics - Dermatology Department (2010) CA
- Fellowship: Stanford University (2007) CA
- Board Certification: American Board of Dermatology, Dermatology (2011)
Publications
-
Clofarabine in refractory Langerhans cell histiocytosis
Rodriguez-Galindo, C., Jeng, M., Khuu, P., & McCarville, M. B. (2008). Clofarabine in refractory Langerhans cell histiocytosis. PEDIATRIC BLOOD & CANCER, 51(5), 703–6. -
Multiple Eruptive Pilomatricomas in a 9-year-Old Boy with Glioblastoma.
Hollmig, S. T., Tollefson, M. M., Kim, J., & Khuu, P. (2013). Multiple Eruptive Pilomatricomas in a 9-year-Old Boy with Glioblastoma. Pediatric Dermatology, 30(6), 756–58. -
Rapidly Involuting Congenital Hemangioma Associated with Profound, Transient Thrombocytopenia
Rangwala, S., Wysong, A., Tollefson, M. M., Khuu, P., Benjamin, L. T., & Bruckner, A. L. (2014). Rapidly Involuting Congenital Hemangioma Associated with Profound, Transient Thrombocytopenia. PEDIATRIC DERMATOLOGY, 31(3), 402–4. -
An open-label study to evaluate sildenafil for the treatment of lymphatic malformations.
Danial, C., Tichy, A. L., Tariq, U., Swetman, G. L., Khuu, P., Leung, T. H., … Lane, A. T. (2014). An open-label study to evaluate sildenafil for the treatment of lymphatic malformations. Journal of the American Academy of Dermatology, 70(6), 1050–57. -
Purified Type I Collagen Wound Matrix Improves Chronic Wound Healing in Patients with Recessive Dystrophic Epidermolysis Bullosa
Gorell, E. S., Leung, T. H., Khuu, P., & Lane, A. T. (2015). Purified Type I Collagen Wound Matrix Improves Chronic Wound Healing in Patients with Recessive Dystrophic Epidermolysis Bullosa. PEDIATRIC DERMATOLOGY, 32(2), 220–25. -
Treatment of keratitis-ichthyosis-deafness (KID) syndrome in children: a case report and review of the literature
Patel, V., Sun, G., Dickman, M., Phuong Khuu, P., & Teng, J. M. C. (2015). Treatment of keratitis-ichthyosis-deafness (KID) syndrome in children: a case report and review of the literature. DERMATOLOGIC THERAPY, 28(2), 89–93. -
Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa.
Siprashvili, Z., Nguyen, N. T., Gorell, E. S., Loutit, K., Khuu, P., Furukawa, L. K., … Marinkovich, M. P. (2016). Safety and Wound Outcomes Following Genetically Corrected Autologous Epidermal Grafts in Patients With Recessive Dystrophic Epidermolysis Bullosa. JAMA, 316(17), 1808–17. -
Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America.
Feinstein, J. A., Jambal, P., Peoples, K., Lucky, A. W., Khuu, P., Tang, J. Y., … Bruckner, A. L. (2018). Assessment of the Timing of Milestone Clinical Events in Patients With Epidermolysis Bullosa From North America. JAMA Dermatology. -
Occupational therapy for epidermolysis bullosa: clinical practice guidelines.
Chan, J. M., Weisman, A., King, A., Maksomski, S., Shotwell, C., Bailie, C., … Khuu, P. (2019). Occupational therapy for epidermolysis bullosa: clinical practice guidelines. Orphanet Journal of Rare Diseases, 14(1), 129. -
Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa.
Eichstadt, S., Barriga, M., Ponakala, A., Teng, C., Nguyen, N. T., Siprashvili, Z., … Tang, J. Y. (2019). Phase 1/2a clinical trial of gene-corrected autologous cell therapy for recessive dystrophic epidermolysis bullosa. JCI Insight, 4(19). -
Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts.
Murrell, D. F., Lucky, A. W., Salas-Alanis, J. C., Woodley, D. T., Palisson, F., Natsuga, K., … Martinez, A. E. (2020). Multidisciplinary Care of Epidermolysis Bullosa during the COVID-19 Pandemic - Consensus: Recommendations by an International Panel of Experts. Journal of the American Academy of Dermatology. -
Physiotherapy for epidermolysis bullosa: clinical practice guidelines.
Weisman, A., Chan, J. M., LaPointe, C., Sjoholm, K., Steinau, K., Artus, K., … Khuu, P. (2021). Physiotherapy for epidermolysis bullosa: clinical practice guidelines. Orphanet Journal of Rare Diseases, 16(1), 406. -
A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa.
Phillips, G. S., Huang, A., Augsburger, B. D., Kaplan, L., Peoples, K., Bruckner, A. L., … Glick, S. A. (2021). A retrospective analysis of diagnostic testing in a large North American cohort of patients with epidermolysis bullosa. Journal of the American Academy of Dermatology.
Clinical Trials
Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.
Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.
Practice Locations
,
,
Important Information about Our Organizations and Physician Affiliation
Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are each independent nonprofit organizations that are affiliated with but separate from each other and from Stanford University. The physicians who provide care at facilities operated by Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners are faculty, foundation, or community physicians who are not employees, representatives, or agents of Stanford Health Care, Stanford Health Care Tri- Valley, or Stanford Medicine Partners. Stanford Health Care, Stanford Health Care Tri-Valley, and Stanford Medicine Partners do not exercise control over the care provided by such faculty, foundation, and community physicians and are not responsible for their actions.
Referring Physicians
PHYSICIAN HELPLINE
Phone: 1-866-742-4811
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Fax: 650-320-9443
Monday–Friday, 8 a.m.–5 p.m.
Stanford Health Care provides comprehensive services to refer and track patients, as well as the latest information and news for physicians and office staff. For help with all referral needs and questions, visit Referral Information.
You may also submit a web referral or complete a referral form and fax it to 650-320-9443 or email the Referral Center at ReferralCenter@stanfordhealthcare.org.
- Send referrals online
- Place radiology and lab orders
- View referral status
- Access medical records